(Q30342973)

20 June 2017

1 reference

title

From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza. (English)

1 reference

20 June 2017

0 references

1 reference

John M Wood

1

1 reference

20 June 2017

James S Robertson

series ordinal

2

1 reference

20 June 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

Nature Reviews Microbiology

20 June 2017

published in

1 reference

20 June 2017

volume

2

1 reference

20 June 2017

issue

10

1 reference

20 June 2017

page(s)

842-847

1 reference

1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants.

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Aspects of virulence in ferrets exhibited by influenza virus recombinants of known genetic constitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Summary of Clinical Trials of Influenza Virus Vaccines in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Mortality associated with influenza and respiratory syncytial virus in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

The 1918 influenza virus: A killer comes into view

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

The structure and receptor binding properties of the 1918 influenza hemagglutinin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Receptor binding properties of human and animal H1 influenza virus isolates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Lethal H5N1 influenza viruses escape host anti-viral cytokine responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Re-emergence of fatal human influenza A subtype H5N1 disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

The safety of inactivated influenza vaccine in adults and children with asthma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Amplification, expression, and packaging of foreign gene by influenza virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Introduction of site-specific mutations into the genome of influenza virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Generation of influenza A viruses entirely from cloned cDNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Reverse genetics of influenza virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

A DNA transfection system for generation of influenza A virus from eight plasmids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

RNAs of influenza virus recombinants derived from parents of known virulence for man.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Pathogenesis of avian influenza A (H5N1) viruses in ferrets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Antibody Responses and Reactogenicity of Graded Doses of Inactivated Influenza A/New Jersey/76 Whole-Virus Vaccine in Humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO979

31 March 2020

Identifiers

DOI

10.1038/NRMICRO979

1 reference

Dimensions Publication ID

20 June 2017

1039941931

0 references

1 reference